First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
NCT06657222
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
250
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Solid Tumors
HNSCC
SCLC
NSCLC
TNBC - Triple-Negative Breast Cancer
CRC
Interventions
DRUG:
TUB-030
Sponsor
Tubulis GmbH